Towards Personalized Intervention for Alzheimer’s Disease
Open Access
- 28 September 2016
- journal article
- review article
- Published by Oxford University Press (OUP) in Genomics, Proteomics & Bioinformatics
- Vol. 14 (5) , 289-297
Abstract
Alzheimer’s disease (AD) remains to be a grand challenge for the international community despite over a century of exploration. A key factor likely accounting for such a situation is the vast heterogeneity in the disease etiology, which involves very complex and divergent pathways. Therefore, intervention strategies shall be tailored for subgroups of AD patients. Both demographic and in-depth information is needed for patient stratification. The demographic information includes primarily APOE genotype, age, gender, education, environmental exposure, life style, and medical history, whereas in-depth information stems from genome sequencing, brain imaging, peripheral biomarkers, and even functional assays on neurons derived from patient-specific induced pluripotent cells (iPSCs). Comprehensive information collection, better understanding of the disease mechanisms, and diversified strategies of drug development would help with more effective intervention in the foreseeable future.Keywords
Funding Information
- National High-tech R&D Program of China (2015AA020108)
- National Basic Research Program of China (2014CB964901)
- Ministry of Science and Technology of China (2015AA020108, 2014CB964901)
This publication has 97 references indexed in Scilit:
- Apolipoprotein E and Sex Bias in Cerebrovascular Aging of Men and MiceTrends in Neurosciences, 2016
- Music therapy: A nonpharmacological approach to the care of agitation and depressive symptoms for nursing home residents with dementiaDementia, 2015
- The level of Alzheimer-associated neuronal thread protein in urine may be an important biomarker of mild cognitive impairmentJournal of Clinical Neuroscience, 2015
- Understanding Biomarkers of Neurodegeneration: Novel approaches to detecting tau pathologyNature Medicine, 2015
- Hypertension and Inflammation in Alzheimer's Disease: Close Partners in Disease Development and Progression!Journal of Alzheimer’s Disease, 2014
- Selenomethionine Ameliorates Cognitive Decline, Reduces Tau Hyperphosphorylation, and Reverses Synaptic Deficit in the Triple Transgenic Mouse Model of Alzheimer's DiseaseJournal of Alzheimer’s Disease, 2014
- Biomarkers for Predicting Cognitive Decline in those with Normal CognitionJournal of Alzheimer’s Disease, 2014
- Non-invasive assessment of Alzheimer’s disease neurofibrillary pathology using 18F-THK5105 PETBrain, 2014
- Sleep and Alzheimer disease pathology—a bidirectional relationshipNature Reviews Neurology, 2013
- Preventing Alzheimer’s DiseaseScience, 2012